Current management of Hodgkin's disease

The accepted management of Hodgkin's disease has changed markedly in the past two decades. It should be considered a tumor of unifocal origin and potentially one of the most curable cancers, given early diagnosis, careful evaluation, meticulously accurate staging and aggressive, radical treatment. This requires a team effort, is tedious and expensive, and morbidity and mortality remain significant, but the high yield of long remissions and apparent cures justifies this approach to the problem.